BD Pays $175M to Settle SEC Claims it Failed to Report Infusion …

Dec 17, 2024  · BD Pays $175M to Settle SEC Claims it Failed to Report Infusion Pump Repair Costs ... “BD repeatedly painted a misleading picture of its Alaris infusion pump for investors …


$175
OFF

BD Pays $175M To Settle SEC Claims It Failed To Report Infusion …

3 weeks from now

Dec 17, 2024  · BD Pays $175M to Settle SEC Claims it Failed to Report Infusion Pump Repair Costs ... “BD repeatedly painted a misleading picture of its Alaris infusion pump for investors …

medicaldesigndevelopment.com

$175
OFF

SEC.gov | Becton Dickinson To Pay $175 Million For Misleading …

3 weeks from now

Dec 16, 2024  · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

sec.gov

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024  · Dive Brief: BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with …

medtechdive.com

$175
OFF

SEC Dings Becton Dickinson $175m For Misrepresenting Product Risks

3 weeks from now

Dec 19, 2024  · The agency also stated that BD failed to inform investors about serious deficiencies in the device that presented the risk of a recall, and related remedial costs. …

globalrelay.com

$175
OFF

BD Resolves Previously Disclosed SEC Investigation - Yahoo Finance

3 weeks from now

As part of the settlement, BD has agreed to pay $175 million to the SEC, an amount that was reserved and disclosed in the company's fiscal year 2024 Form 10-K and was contemplated in …

yahoo.com

$175
OFF

Becton, Dickinson To Pay $175M To Settle Claims Over Misleading ...

3 weeks from now

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

seekingalpha.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Probe

3 weeks from now

Dec 16, 2024  · Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important …

bloomberglaw.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Probe

3 weeks from now

Dec 16, 2024  · Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most …

bloomberg.com

$175
OFF

BD To Pay SEC $175M To Settle Alaris Investigation

3 weeks from now

Dec 17, 2024  · Franklin Lakes, New Jersey–based BD agreed to pay $175 million to the SEC. This adds to an $85 million settlement to resolve a class action suit in New Jersey about a …

massdevice.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Investigation …

3 weeks from now

Dec 17, 2024  · The Securities and Exchange Commission announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as …

jeffnewmanlaw.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024  · The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris …

businessinsider.com

$175
OFF

Becton Dickinson Pays $175M For Misleading Investors About …

3 weeks from now

Dec 18, 2024  · Becton Dickinson medical device company will pay $175 million for "repeatedly" misleading investors about its Alaris infusion pump, a product the company knew was flawed …

complianceweek.com

$175
OFF

BD Pays $175M To Resolve Alaris Infusion Pump Financial Fraud …

3 weeks from now

The settlement with the SEC closes out safety issues around the company’s Alaris infusion pumps. BD reportedly failed to alert investors or the FDA of known problems with the infusion …

citeline.com

$175
OFF

BD Resolves SEC Investigation With $175 Million Settlement

3 weeks from now

Summary. Becton Dickinson & Co (BDX, Financial), a prominent global medical technology company, announced on December 16, 2024, that it has reached a settlement with the U.S. …

gurufocus.com

$175
OFF

BD Settles SEC Investigation With $175m Agreement, No Financial

3 weeks from now

Dec 17, 2024  · Becton, Dickinson and Company (NYSE: BDX), a global leader in medical technology, has announced the resolution of a longstanding SEC investigation settlement …

business-news-today.com

$175
OFF

BD Settles SEC Investigation Into Alaris System For $175M

3 weeks from now

Dec 17, 2024  · Becton, Dickinson and Co. reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve an investigation related to allegations that the …

bioworld.com

$175
OFF

BD To Pay SEC $175M To Settle Alaris Investigation - NewsBreak

3 weeks from now

BD (NYSE:BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system. The investigation relates to prior public disclosures …

newsbreak.com

$175
OFF

BD To Pay SEC $175M To Settle Alaris Investigation - NewsBreak

3 weeks from now

The investigation relates to prior public disclosures and SEC reporting regarding Alaris, an infusion pump system. BD neither admits nor denies the findings of an SEC order related to …

newsbreak.com

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024  · BD to pay $175M to settle charges of misleading investors on Alaris pump. Leave a Comment / By / 17/12/2024 17/12/2024. BD will pay a civil penalty to resolve charges it …

convitgroup.com

FAQs about BD Pays $175M to Settle SEC Claims it Failed to Report Infusion … Coupon?

Why did the SEC settle charges against BD?

The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. ...

Why did BD pay $175 million to the SEC?

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an investigation concerning past public disclosures and SEC reporting related to the BD Alaris System. ...

Does BD disclose SEC findings?

In its own news release, BD said it neither admits nor denies any of the SEC's findings, adding that it is not updating its fiscal 2025 guidance given it disclosed a settlement in its fiscal 2024 Form 10K. More on Becton, Dickinson ...

Why did Becton Dickinson pay a $175m civil penalty?

Play(3min) krblokhin The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued sales of and the costs of correcting software flaws associated withthe company's Alaris infusion pump. ...

Did BD pay a $175 million civil penalty?

BD agreed to pay a $175 million civil penalty. According to the SEC’s order, BD determined in 2016 that software changes made to the Alaris pump required regulatory clearance from the Food and Drug Administration (FDA). ...

Why did Dickinson settle with SEC for $175m?

Market Data Sources © 2024 Seeking Alpha Becton, Dickinson settles with SEC for $175M over misleading investors on software flaws in Alaris pumps. Read more here. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension